Biogen Idec, Inc. (BIIB) Tops Q3 EPS by 32c
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q3 EPS of $1.91, $0.32 better than ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
